133 related articles for article (PubMed ID: 1835868)
1. Emerging clinical uses for GM-CSF.
Scarffe JH
Eur J Cancer; 1991; 27(11):1493-504. PubMed ID: 1835868
[No Abstract] [Full Text] [Related]
2. Granulocyte colony-stimulating factors.
Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
[No Abstract] [Full Text] [Related]
3. Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF). A review of recent experience.
Costello RT
Acta Oncol; 1993; 32(4):403-8. PubMed ID: 8369127
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of human granulocyte-macrophage colony-stimulating factor.
Sakamoto KM; Gasson JC
Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227
[TBL] [Abstract][Full Text] [Related]
5. Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.
Fleischman RA
Am J Med Sci; 1993 Apr; 305(4):248-73. PubMed ID: 7682752
[TBL] [Abstract][Full Text] [Related]
6. [GM-CSF and G-CSF: cytokines in clinical application].
Ruef C; Coleman DL
Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
[TBL] [Abstract][Full Text] [Related]
7. Colony-stimulating factors: a new step in clinical practice. Part I.
Nemunaitis J
Ann Med; 1992 Dec; 24(6):439-44. PubMed ID: 1485935
[TBL] [Abstract][Full Text] [Related]
8. Haemopoietic growth factors and childhood cancer.
Hann IM
Eur J Cancer; 1995; 31A(9):1476-8. PubMed ID: 7577075
[No Abstract] [Full Text] [Related]
9. G-CSF and GM-CSF in clinical trials.
Antman KH
Yale J Biol Med; 1990; 63(5):387-410. PubMed ID: 1705737
[TBL] [Abstract][Full Text] [Related]
10. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
[No Abstract] [Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor (GM-CSF): a variety of possible applications in clinical medicine.
Weiss M; Belohradsky BH
Infection; 1992; 20 Suppl 2():S81-3. PubMed ID: 1493939
[No Abstract] [Full Text] [Related]
12. Use and toxicity of the colony-stimulating factors.
Schriber JR; Negrin RS
Drug Saf; 1993 Jun; 8(6):457-68. PubMed ID: 7687134
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of recombinant human colony-stimulating factors.
Klingemann HG
CMAJ; 1989 Jan; 140(2):137-42. PubMed ID: 2642725
[TBL] [Abstract][Full Text] [Related]
14. Colony-stimulating factors for the management of neutropenia in cancer patients.
Dale DC
Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
[TBL] [Abstract][Full Text] [Related]
15. [Pyoderma gangrenosum aggravated by GM-CSF administration].
Perrot JL; Benoit F; Segault D; Jaubert J; Guyotat D; Claudy A
Ann Dermatol Venereol; 1992; 119(11):846-8. PubMed ID: 1301698
[No Abstract] [Full Text] [Related]
16. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications.
Hill AD; Naama HA; Calvano SE; Daly JM
J Leukoc Biol; 1995 Dec; 58(6):634-42. PubMed ID: 7499960
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.
Ganser A; Ottmann OG; Hoelzer D
Stem Cells; 1993 Nov; 11(6):465-73. PubMed ID: 8111306
[No Abstract] [Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor.
Devereux S; Linch DC
Biotherapy; 1990; 2(4):305-13. PubMed ID: 2148492
[No Abstract] [Full Text] [Related]
19. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
[TBL] [Abstract][Full Text] [Related]
20. The potential role of granulocyte-macrophage colony stimulating factor (GM-CSF) in cancer chemotherapy.
Cebon JS; Morstyn G
Cancer Surv; 1990; 9(1):131-55. PubMed ID: 2276111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
